Introduction

I
n November 2013, the U.S. Preventive Services Task Force (USPSTF) convened an expert forum on behavioral counseling interventions. The forum provided a unique opportunity to bring together NIH, CDC, and Agency for Healthcare Research and Quality (AHRQ) leaders, leading behavioral counseling researchers, and members of the USPSTF to discuss issues related to optimizing evidence-based behavioral counseling recommendations. The meeting focused on optimizing Task Force methods for developing counseling recommendations, optimizing behavioral counseling research that forms the basis for evidence-based recommendations, and expanding opportunities for funded research that addresses gaps identified by the Task Force in the evidence reviews conducted as part of the recommendation process. The agenda and roster of participants is included in the Appendix (available online).
Why Behavioral Counseling?
Underlying the importance of behavioral counseling as a clinical preventive service are four foundational premises. First, the level of spending on health and health care in the U.S. does not lead to better population health status. 1 For example, among 34 members of the Organization for Economic Cooperation and Development, the U.S. ranks below average across multiple health status measures, including infant mortality (31/34); life expectancy from birth (26/34); and obesity among children (30/ 34) and among adults (34/34). 1 Second, behavioral risk factors contribute substantially to the leading causes of premature morbidity and mortality, including heart disease, cancer, chronic lower respiratory disease, and diabetes. 2 So great is their contribution that tobacco use, poor diet and physical activity, and alcohol consumption have been identified as the top three actual causes of death. 3 Behavioral patterns are estimated to contribute 40% to premature death, greater than genetic disposition (30%) and social circumstances (15%); environmental exposures (5%); and health care (10%) combined. 2 The economic impact of behavioral risk factors is the third premise. In 2011, U.S. expenditures on health care were $2.7 trillion. 4 Of every dollar spent on health care, $0.75 goes for treatment of preventable diseases (this cost rises in Medicare to $0.96 and in Medicaid to $0.83). 5 Thus, addressing behavioral risk factors has tremendous potential and brings us to the fourth premise: the healthcare setting has great promise as a channel for counseling to address behavioral risk factors. The overwhelming majority of individuals in the U.S. have at least one visit with a primary care provider annually. 6 Primary care providers are respected, credible professionals who can motivate and encourage behavior change. The healthcare visit often provides a "teachable moment" for personalizing messages and support for behavioral counseling. 7 Health information technology or electronic medical records can facilitate identification of individuals appropriate for counseling interventions and referral, as well as continuity and follow-up opportunities in subsequent visits. 8 Realizing this promise requires a science base for effective behavioral counseling interventions, which was the focus of the USPSTF forum.
U.S. Preventive Services Task Force Methods
The USPSTF is an independent panel of nonfederal experts in prevention and evidence-based medicine that makes recommendations on clinical preventive services to primary care clinicians. The scope for clinical preventive services includes screening tests, counseling, and preventive medications. Services are offered in or referred from a primary care setting. As preventive services, the recommendations apply to individuals (adults and children) with no signs or symptoms of that disease. The USPSTF was an early adopter in basing its recommendations on rigorous systematic reviews of existing peer-reviewed evidence, now considered a standard for trustworthy recommendations. 9 The Task Force does not conduct research studies; it reviews and assesses existing research. Both the benefits and harm of each preventive service are evaluated. As background to the issues discussed at the forum, we provide a brief overview of the Task Force's general methods for developing recommendations including the methods used to conduct the evidence reviews that form the foundation of Task Force recommendations. This overview is not intended to be a comprehensive summary; more detailed information can be found at www.uspreventiveservices taskforce.org. Figure 1 summarizes the sequence of procedures for developing a recommendation statement. Several features of these procedures merit emphasis. First, there are multiple opportunities for public input to the work of the Task Force with regard to nomination of topics, review of the systematic review work plan, and review of the draft recommendation. Second, the development of a recommendation from work plan development through evidence review to drafting and finalizing a recommendation takes approximately 18-24 months. The Task Force works with partner organizations and experts to obtain input and peer review of key products, including work plans, evidence reports, and draft recommendations.
General Procedures for Developing a Recommendation Statement
Topic nominations can suggest a new preventive service topic or recommend reconsideration of an existing topic owing to the availability of new evidence, changes in the public health burden on the condition, or the availability of new interventions supported by new evidence. Nominations are accepted year round and are considered by the USPSTF at its three annual meetings. The four main considerations in prioritizing and selecting topics are as follows:
1. whether the topic is within the scope of the Task Force (e.g., does it focus on prevention versus diagnosis and treatment and is it relevant to the primary care setting?); 2. the public health importance of the condition to be prevented, including the burden of suffering and the expected effectiveness of the preventive service; 3. the potential of the Task Force recommendation to have an impact on clinical practice (e.g., is there an existing controversy or is there believed to be a gap between evidence and practice?); and 4. the intensity of resources needed (e.g., How broad does the evidence review need to be?).
Developing the Systematic Review
For each new or updated topic, a subset of three to four Task Force members (leads) and a medical officer from AHRQ work with an Evidence-Based Practice Center (EPC) to develop a work plan for the systematic evidence review to be conducted by the EPC. The work plan uses established USPSTF approaches 11 to define the topic scope and outline the series of discrete clinical actions from patient identification through to health outcomes as required to achieve the net impact of the preventive service; these specify the key issues for systematic review evaluation as well. The work plan outlines the review approach to searching and selection of the evidence and any contextual issues to be addressed. After public comment and revision, the USPSTF leads approve a final work plan for public posting and to guide the EPC in conducting the review.
Once the topic is scoped, the systematic review adheres to the final work plan through a multistep methodologic process with six additional phases ( Table 1) . Scientific databases and other sources are searched to locate all potentially relevant studies; these are screened for relevance and qualified through critical appraisal to be reasonably free of study-level bias, with key data from included articles abstracted into standardized evidence tables. Outcomes are summarized across studies qualitatively, as well as quantitatively when appropriate, to support decision making by the USPSTF. In the final phase, systematic review results are shared with the USPSTF, peer reviewers, and others for consideration and input prior to revision and publication of final findings in the public domain. Even as the systematic review itself is completed, the EPC continues to support the USPSTF as it evaluates the body of evidence. This "evidence chaperone" role represents an active handoff of the evidence synthesis to the decision makers to maintain the integrity of the review throughout its application in developing a recommendation statement by the USPSTF. In other words, the EPC participates in calls and reviewing documents to ensure that there is clear understanding of the reviewed evidence and consistency in the communication of the evidence basis for the recommendation statement with the systematic review.
Task Force Evaluation of Evidence From the Systematic Review
The evidence review provides the foundation on which the Task Force leads assess the net benefit of a preventive service. Net benefit means that the Task Force considers the balance of the potential health benefits and harm of a preventive service. As shown in Table 2 , recommendations can have letter grades of A, B, C, D, or I.
There are six main considerations in evaluating the available evidence from the systematic review. The first three relate to the quality of the research studies in the evidence review. The Task Force focuses on whether the studies have the appropriate research design; the quality of the study components (internal validity); and the applicability of the studies to the general U.S. primary care population and treatment models (external validity). The other three considerations focus on the number and size of studies that have been conducted that address the key questions in the analytic framework (precision of the evidence); consistency in the study findings; and other factors that may support or undermine potential conclusions, such as the presence or absence of a doseresponse effect or fit with a biological model. Together, these considerations help the Task Force determine whether there is convincing evidence that is derived from several high-quality studies with consistent, logical results that are generalizable to the U.S. primary care population and setting; adequate evidence, when most but not all of the six considerations are answered favorably; or inadequate evidence, in cases where the evidence is lacking, conflicting, or the studies are of poor quality individually or in aggregate.
With convincing or adequate evidence, the Task Force can move forward in determining the levels of certainty for net benefit. High certainty requires convincing evidence (consistent results from well-designed, wellconducted studies in representative primary care populations) of overall assessed effects of the preventive service on both beneficial and harmful health outcomes. With high certainty, the USPSTF judges that, given the size and quality of the evidence, conclusions are unlikely to change with future studies. Moderate certainty indicates a determination that the available evidence is sufficient to determine the effects of the preventive service on health outcomes. There is some constraint on confidence in the evidence based on factors such as the number, size, or quality of individual studies; inconsistency of findings across studies; limited generalizability to routine primary care practice; or a lack of coherence in the chain of evidence. Given these constraints, it is possible for the conclusions to change with future research.
Low certainty indicates either that the overall evidence base is inadequate or that the available evidence is insufficient to assess overall effects on health outcomes because of a limited number or size of studies, important flaws in study design or methods, inconsistency of findings across individual studies, gaps in the chain of evidence, findings that are not generalizable to the primary care population, or lack of information on important health outcomes. This conclusion could change with more information from future studies that mitigate these limitations.
Using the U.S. Preventive Services Task Force Recommendation Grid
The USPSTF's overall judgment of their certainty of net benefit based on results of the 
S. Preventive Services Task Force Recommendation Letter Grade Definitions
Grade Definition A The USPSTF recommends the service. There is high certainty that the net benefit is substantial.
B
The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.
C
The USPSTF recommends selectively offering or providing this service to individual patients based on professional judgment and patient preferences. There is at least moderate certainty that the net benefit is small.
D
The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.
I Statement
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined. EPC evidence review across the key questions articulated in the analytic framework coalesces with the determination of a letter grade recommendation from the Task Force. Figure 2 illustrates the recommendation grid used by the Task Force to arrive at a letter grade. As discussed above, the Task Force evaluates the evidence for benefits of a preventive service in terms of improved outcomes in individuals without signs or symptoms of the target condition (e.g., cardiovascular disease, cancer) along with evidence for any harm associated with the preventive service (e.g., overdiagnosis and over-treatment, stigma associated with labeling, radiation exposures) and assesses the level of net benefit (benefits minus harm). Depending on the preventive service, it may be possible to quantify net benefit (e.g., lives saved by a preventive service minus lives lost from negative effects of the service). Other services (e.g., behavioral counseling interventions) are rarely associated with serious morbidity or mortality, and so the assessment is often less quantitative. Assuming evidence for benefits and reasonable data or assumptions about harm, the Task Force determines whether the net benefit is substantial, moderate, small, or of no benefit/negative. The letter grade is determined based on both the magnitude of the net benefit and the certainty with which that determination was made. As shown in Figure 2 , a preventive service for which there is a substantial net benefit with high certainty receives a letter grade of A. Recommendations with a B letter grade are for services that demonstrate substantial benefit with high certainty or moderate benefit with high or moderate certainty. Both A and B letter grades indicate a recommendation for primary care providers to routinely provide the preventive service. Preventive services with moderate to high certainty of a small net benefit are given a C letter grade. These services are not routinely recommended, but are recommended to be selectively provided based on clinical judgment and patient preferences. Any preventive service that evidences no net benefit or a negative net benefit (i.e., harm outweighs benefits) is given a D letter grade, and the service is not recommended in primary care practice. For preventive services with low certainty, the available evidence is insufficient for making a recommendation and those services are given an I letter grade.
The approach to evidence by the USPSTF has been previously articulated, 11, 14, 15 with specific consideration of the challenges of behavioral counseling topics. 16, 17 As detailed in the rest of this supplement, many challenges remain and this supplement represents renewed efforts to address them. To provide a brief example, we consider a recently updated behavioral counseling recommendation, "Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse: U.S. Preventive Services Task Force Recommendation Statement." 18 In May 2013, the USPSTF published its final updated recommendation for screening, behavioral counseling, and referral in primary care to reduce alcohol misuse. The complete recommendation and evidence report can be obtained at www.uspreventiveservicestask force.org/uspstf/uspsdrin.htm.
19 Figure 3 shows the analytic framework used by the Task Force and EPC that included six key questions related to screening, intervention, behavior change, long-term health outcomes, and adverse effects or harm of either screening or intervention. The framework also noted particular subgroups of interest. Figure 4 shows the disposition of articles reviewed for inclusion in the evidence review. Ultimately, the quantitative synthesis included 19 of 29 studies identified from a full-text review of 718/6,265 records identified in the scientific database search. Figure 5 shows forest plots for three different measures of alcohol consumption from the included studies. 19 Overall, there was evidence that interventions to reduce alcohol misuse in screening-identified individuals reduced the frequency of binge drinking episodes, total number of drinks per week, and prevalence of drinking more than recommended limits. These data confirmed the findings of the previous review. 20 However, changes in drinking behavior are not inherently clear with respect to health benefits. Thus, the systematic review included scientific literature linking increased alcohol consumption levels to higher risk for traumatic injury or death, which the Task Force accepted as adequate evidence of a health benefit. 21, 22 The Task Force concluded that the harm associated with screening and intervention was no greater than small. Thus, the final evidence appraisal was that there is a moderate net benefit to alcohol misuse screening and brief behavioral counseling interventions in the primary care setting for adults aged 18 years or older. Using the recommendation grid, the USPSTF assigned a B grade to a recommendation that clinicians screen adults aged 18 years or older for alcohol misuse and provide individuals engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse. This recommendation blends evidence on the effect on alcohol use and the evidence for a relationship between alcohol use and morbidity and mortality from traumatic injury or death.
The Task Force concluded that the evidence on alcohol misuse screening and brief behavioral counseling interventions in the primary care setting for adolescents is insufficient and so the balance of benefits and harm cannot be determined. Using the recommendation grid, the Task Force assigned an I statement to this conclusion.
This topic also illustrates some of the current challenges in developing behavioral counseling recommendations that were recently outlined. 17 These challenges include clearly defining study populations, feasibility of practice or referral for counseling, defining the components and intensity of interventions, assessing potential adverse effects, defining behavioral outcome measures, and linking behavior change to health outcomes.
As noted above, the Task Force concluded that there is insufficient evidence regarding screening and intervention for alcohol misuse among adolescents. Although there is a robust literature related to adolescent and young adult alcohol misuse interventions on college campuses, the social setting and intervention opportunities cannot be extrapolated to a primary care setting. Second, it was not possible in this recommendation to specify with certainty the required elements or level of intensity of intervention for reproducing the trial effects in community practice. When lacking a common language for describing intervention components, it can appear that different studies are testing unique approaches. Moreover, because more-intensive interventions are usually applied to higher-risk individuals, intervention intensity is often confounded by population risk. Finally, intervention intensity is a multidimensional construct that may be represented by total hours of intervention, hours of interpersonal contact, number of contacts, duration of time over which intervention contacts occur, format of intervention, training and skills level of interventionists, and other factors. These multiple factors are rarely reported consistently and there is no clear metric for combining them into a formula for clinical settings. Thus, we are often left with "best practice" examples of what works with little evidencebased guidance for tailoring to specific healthcare settings.
Third, behavioral outcomes are proxies for health outcomes, but are difficult to quantitatively relate to these. Often the outcome measurement approach varies and must be converted to standardized mean differences or recalculated to represent the same approximate construct. In the alcohol misuse example, conversions to mean drinks per week could be done across many studies, but these mean changes were not as clearly meaningful in terms of health outcomes as, for example, mean blood pressure changes would be. Two of three outcomes for alcohol misuse could be calculated as proportions, allowing risk difference summarization and conversion to number needed to screen or treat. The proportion benefiting is rarely reported in behavioral counseling trials, but is extremely useful for decision makers. In these examples, choices about which outcomes should be primary and when to assume homogeneity sufficient to combine studies meta-analytically are hidden, critical methodologic issues that can be particularly challenging and prone to bias or error for these types of topics.
Fourth, evidence for harm is generally less robust than for benefits across all types of clinical preventive services and is infrequently reported for behavioral counseling. Although the Task Force generally considers the potential adverse effects of behavioral counseling to be small, there can be important effects that warrant assessment. For example, potential adverse effects of addressing alcohol misuse could include increased use of other substances, stigma, labeling, discrimination, or interference with the patient-provider relationships. 
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Although the methods for clinically based behavioral counseling are still developing, systematic reviewers and guideline developers like the USPSTF face everincreasing scrutiny, time, and resource pressures. Given the complexity of the interventions, the intermediate nature of most of the outcomes, and the importance of being able to feasibly provide or refer patients to effective interventions, behavioral counseling topics are challenging. The remainder of this supplement is devoted to the exploration of collaborative perspectives among researchers, research funders, and the USPSTF in order to optimize the evidence base and reduce the barriers to realizing the impact of evidence-based behavioral counseling interventions in primary care settings. Administrative and logistical support for this paper was provided by AHRQ through contract HHSA290-2010-00004i, TO 4. No financial disclosures were reported by the authors of this paper.
